2027 ICD-10-CM Diagnosis Code T47.5X5SAdverse effect of digestants, sequela

ICD-10-CM Codes›S00–T88›T36-T50›T47

ICD-10-CM T47.5X5S
CMSSource: CMS FY 2027 ICD-10-CM dataset · Effective Oct 1, 2026 – Sep 30, 2027

T47.5X5S is a billable ICD-10-CM diagnosis code for adverse effect of digestants, sequela. The 7th character S marks it as a sequela code, which reports a problem that remains after the original condition has resolved. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 922 through 923. The code is not accepted as a principal diagnosis by the Medicare Code Editor and exempt from POA reporting. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Poisoning/toxic effect/adverse effects/underdosing, sequela.

Code Identity

ICD-10-CM Code
T47.5X5S
Billable Status
Yes — Valid for Submission
Code Describes
Adverse effect of digestants, sequela
Short Description
Adverse effect of digestants, sequela
Same as the full description in the CMS dataset.
Parent Code
Adverse effect of digestants

Code Classification

ChapterS00–T88Injury, poisoning and certain other consequences of external causes
SectionT36-T50Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
CategoryT47Poisoning by, adverse effect of and underdosing of agents primarily affecting the gastrointestinal system
This CodeT47.5X5SAdverse effect of digestants, sequela

Code EditsBilling

Medicare Code Editor checks that affect claim validity for T47.5X5S.

There are selected codes that describe a circumstance which influences an individual's health status but not a current illness or injury, or codes that are not specific manifestations but may be due to an underlying cause. These codes are considered unacceptable as a principal diagnosis.

Present on Admission (POA)Billing

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Adverse reaction to bile acid and/or bile acid derivative
  • Adverse reaction to chenodeoxycholic acid and/or ursodeoxycholic acid
  • Adverse reaction to digestant
  • Adverse reaction to lipotropic drugs
  • Adverse reaction to oil
  • Adverse reaction to pancreatin
  • Adverse reaction to papain
  • Adverse reaction to pepsin
  • Chenodeoxycholic acid adverse reaction
  • Dehydrocholic acid adverse reaction
  • Peppermint oil adverse reaction

Coding GuidelinesGuidance

When coding an adverse effect of a drug that has been correctly prescribed and properly administered, assign the appropriate code for the nature of the adverse effect followed by the appropriate code for the adverse effect of the drug.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of agents primarily affecting the gastrointestinal system (T47). Use the following options for the applicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2027, published by CMS and the National Center for Health Statistics.

Instructional NotesGuidance

Instructions from the official ICD-10-CM Tabular List that apply to T47.5X5S: its own notes plus those printed at T47, block T36-T50, and Chapter 19. A note printed at a category, block or chapter applies to every code under it.

Includes

Further defines, or gives examples of, the content of the category.

From Block T36-T50 Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances applies to 3,186 codes
  • adverse effect of correct substance properly administered
  • poisoning by overdose of substance
  • poisoning by wrong substance given or taken in error
  • underdosing by (inadvertently) (deliberately) taking less substance than prescribed or instructed

Excludes1

Not coded here: the excluded code is never reported together with this one, unless the two conditions are unrelated.

From Block T36-T50 Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances applies to 3,186 codes
  • toxic reaction to local anesthesia in pregnancy (O29.3-)

Excludes2

Not included here: the excluded condition is not part of this code, but a patient may have both, so both codes may be reported.

From Block T36-T50 Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances applies to 3,186 codes
  • abuse and dependence of psychoactive substances (F10-F19)
  • abuse of non-dependence-producing substances (F55.-)
  • immunodeficiency due to drugs (D84.821)
  • drug reaction and poisoning affecting newborn (P00-P96)
  • pathological drug intoxication (inebriation) (F10-F19)
From Chapter 19 (S00-T88) Injury, poisoning and certain other consequences of external causes applies to 41,187 codes

Code First

The underlying condition named in the note is sequenced before this code.

From Block T36-T50 Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances applies to 3,186 codes
  • for adverse effects, the nature of the adverse effect, such as:
  • adverse effect NOS (T88.7)
  • aspirin gastritis (K29.-)
  • blood disorders (D56-D76)
  • contact dermatitis (L23-L25)
  • dermatitis due to substances taken internally (L27.-)
  • nephropathy (N14.0-N14.2)

Use Additional Code

Add a second code, after this one, to fully describe the condition.

From Block T36-T50 Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances applies to 3,186 codes
  • code(s) to specify:
  • manifestations of poisoning
  • underdosing or failure in dosage during medical and surgical care (Y63.6, Y63.8-Y63.9)
  • underdosing of medication regimen (Z91.12-, Z91.13-)
From Chapter 19 (S00-T88) Injury, poisoning and certain other consequences of external causes applies to 41,187 codes
  • code to identify any retained foreign body, if applicable (Z18.-)

Notes

General instructions on how these codes are used.

From Block T36-T50 Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances applies to 3,186 codes
  • The drug giving rise to the adverse effect should be identified by use of codes from categories T36-T50 with fifth or sixth character 5.
From Chapter 19 (S00-T88) Injury, poisoning and certain other consequences of external causes applies to 41,187 codes
  • Use secondary code(s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code
  • The chapter uses the S-section for coding different types of injuries related to single body regions and the T-section to cover injuries to unspecified body regions as well as poisoning and certain other consequences of external causes.

7th Character

Every code in the category takes a 7th character from the listed values, with the placeholder X filling any empty positions before it.

From T47 Poisoning by, adverse effect of and underdosing of agents primarily affecting the gastrointestinal system applies to 180 codes
  • The appropriate 7th character is to be added to each code from category T47
  • Ainitial encounter
  • Dsubsequent encounter
  • Ssequela this code

Source: CMS ICD-10-CM Tabular List. How to read instructional notes.

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR INJ075
Poisoning/toxic effect/adverse effects/underdosing, sequela
Default principal diagnosis: inpatient No · outpatient Yes

Table of Drugs and ChemicalsClinical

Substances in the Table of Drugs and Chemicals that reference this code family. Always confirm in the Tabular List before coding.

SubstanceAccidentalSelf-harmAssaultUndeter­minedAdverse
Effect
Under­dosing
AmylaseT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
Anise oilT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
AntiflatulentT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
b-galactosidaseT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
BetaineT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
Bile saltsT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
CarminativeT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
Chenodeoxycholic acidT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
ChenodiolT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
CholagoguesT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
CholereticT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
Cholic acidT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
Citric acidT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
Cytochrome CT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
DecholinT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
Dehydrocholic acidT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
DiastaseT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
Digestant NECT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
DillT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
ElastaseT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
Enzyme NEC::gastricT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
Enzyme NEC::intestinalT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
FlorantyroneT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
b-GalactosidaseT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
Gastric enzymesT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
GentianT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
GingerT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
Glutamic acidT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
Hydrochloric acid (liquid)::medicinal (digestant)T47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
LipancreatinT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
Ox bile extractT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
PancreatinT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
PancrelipaseT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
PapainT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
Papain::digestantT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
Peppermint (oil)T47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
PepsinT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
Pepsin::digestantT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
PhenylpropanolT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
ProteaseT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6
TilactaseT47.5X1T47.5X2T47.5X3T47.5X4T47.5X5T47.5X6

Patient EducationClinical

Drug Reactions

Most of the time, medicines make our lives better. They reduce aches and pains, fight infections, and control problems such as high blood pressure or diabetes. But medicines can also cause unwanted reactions, such as drug interactions, side effects, and allergies.

The full article covers:

  • What is a drug interaction?
  • What are side effects?
  • What are drug allergies?
  • How can I stay safe when taking medicines?

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert T47.5X5S to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
909.5 Lte efct advrs efct drug
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.
ICD-9-CM
E943.4 Adv eff digestants
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2026No changes
FY 2027CurrentCurrent code set, no changesEffective October 1, 2026 through September 30, 2027.

Questions About T47.5X5SOverview

What is the ICD-10 code for adverse effect of digestants, sequela?

The ICD-10-CM code for adverse effect of digestants, sequela is T47.5X5S (sometimes written as T475X5S). It is billable on HIPAA-covered claims from October 1, 2026 through September 30, 2027.

Is T47.5X5S (Adverse effect of digestants) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report adverse effect of digestants, sequela on HIPAA-covered claims from October 1, 2026 through September 30, 2027.

What does the 7th character S in T47.5X5S mean?

The final character S makes this a sequela code: it reports a lingering problem that remains after the adverse effect of digestants itself has resolved, not the original event.

What MS-DRG does T47.5X5S group to?

On inpatient claims, adverse effect of digestants, sequela maps to MS-DRG 923, 922, with relative weights from 0.9980 to 1.6248 depending on complications. Higher weights mean higher Medicare reimbursement.

Can T47.5X5S be a principal diagnosis?

No. The Medicare Code Editor rejects this code as a principal diagnosis because adverse effect of digestants, sequela describes a circumstance that influences health status rather than a current illness. Report it as a secondary diagnosis.